Steve Merrick

Executive Chairman at NorthStar Medical Radioisotopes, LLC

Steve Merrick has a diverse work experience spanning several industries. Steve is currently the Chief Executive Officer of NorthStar Medical Radioisotopes, LLC, an emerging leader in Radiopharmaceutical development and commercialization. Steve is responsible for overseeing the company's operations and production of patient doses. Prior to this role, Steve held various positions at NorthStar, including President and Chief Executive Officer, President and Chief Operating Officer, and Senior Vice President and Chief Operating Officer.

Before joining NorthStar, Steve worked at Baxter International Inc. as the Vice President of Hospital - International Marketing. In this role, they led the International Marketing Team and focused on including international customer insights in global strategies and driving execution at the country level.

Steve also served as the Senior Vice President and President of International Commercial Operations at Mallinckrodt Pharmaceuticals, where they were responsible for commercial operations in approximately 90 countries.

Steve's experience at Bristol-Myers Squibb included roles such as Vice-President of Strategic Projects - Intercontinental, President & General Manager of Brazil, Senior Director / Vice-President of Strategy and Operations - Worldwide Pharmaceuticals, and Senior Director of Infectious Disease, Coumadin and Optimized Brands - US Operations. Steve successfully implemented growth strategies, negotiated partnerships, and managed sales teams during their time at the company.

Early in their career, Steve worked at Eli Lilly and Company as a Financial Analyst and Commercial Manager in the United Kingdom. Overall, their experience spans across leadership, strategy, operations, marketing, and commercial roles in the healthcare industry.

Steve Merrick obtained an MBA degree in Business from the London Business School, which they pursued from 1990 to 1992. Prior to that, they completed a BSc (Honours) in Engineering Science from the University of Exeter. Additionally, they received an Executive Officer Commission from Britannia Royal Naval College. The exact time periods for the latter two qualifications were not provided.

Links

Previous companies

Mallinckrodt logo
Bristol-Myers Squibb logo

Timeline

  • Executive Chairman

    June 1, 2023 - present

  • Chief Executive Officer

    July, 2022

  • President and Chief Executive Officer

    September, 2018

  • Board Member

    October, 2017

  • Senior Vice President and Chief Operating Officer

    March, 2016